Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126754911 | 12675491 | 1 | I | 20160808 | 20160823 | 20160823 | EXP | JP-ACCORD-043371 | ACCORD | TESHIGAWARA S, KATADA Y, MAEDA Y, YOSHIMURA M, KUDO-TANAKA E, TSUJI S, ET AL. HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS WITH LEUKOENCEPHALOPATHY IN A PATIENT WITH DERMATOMYOSITIS ACCOMPANIED WITH PERIPHERAL T-CELL LYMPHOMA: A CASE REPORT. J MED CASE REP. 2016 AUG 2;10:212. | 17.00 | YR | T | M | Y | 0.00000 | 20160823 | OT | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126754911 | 12675491 | 1 | PS | ETOPOSIDE. | ETOPOSIDE | 1 | 120 MG/BODY | U | 74513 | 75 | MG/M**2 | /wk | |||||||
| 126754911 | 12675491 | 2 | SS | METHOTREXATE. | METHOTREXATE | 1 | 5.6 G/BODY | 40716 | |||||||||||
| 126754911 | 12675491 | 3 | SS | TACROLIMUS. | TACROLIMUS | 1 | 91195 | ||||||||||||
| 126754911 | 12675491 | 4 | SS | CYTARABINE/CYTARABINE HYDROCHLORIDE/CYTARABINE OCFOSFATE | CYTARABINE | 1 | 0 | 6 | G | ||||||||||
| 126754911 | 12675491 | 5 | SS | DEXAMETHASONE. | DEXAMETHASONE | 1 | U | 0 | 20 | MG | |||||||||
| 126754911 | 12675491 | 6 | SS | METHYLPREDNISOLONE. | METHYLPREDNISOLONE | 1 | 0 | 60 | MG | ||||||||||
| 126754911 | 12675491 | 7 | SS | CYCLOPHOSPHAMIDE/CYCLOPHOSPHAMIDE MONOHYDRATE | CYCLOPHOSPHAMIDE | 1 | 0 | ||||||||||||
| 126754911 | 12675491 | 8 | SS | CICLOSPORIN | CYCLOSPORINE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126754911 | 12675491 | 1 | Histiocytosis haematophagic |
| 126754911 | 12675491 | 2 | Peripheral T-cell lymphoma unspecified |
| 126754911 | 12675491 | 3 | Histiocytosis haematophagic |
| 126754911 | 12675491 | 4 | Peripheral T-cell lymphoma unspecified |
| 126754911 | 12675491 | 5 | Leukoencephalopathy |
| 126754911 | 12675491 | 6 | Leukoencephalopathy |
| 126754911 | 12675491 | 7 | Leukoencephalopathy |
| 126754911 | 12675491 | 8 | Histiocytosis haematophagic |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126754911 | 12675491 | OT |
| 126754911 | 12675491 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126754911 | 12675491 | Drug ineffective | |
| 126754911 | 12675491 | Peripheral T-cell lymphoma unspecified | |
| 126754911 | 12675491 | Sepsis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |